Fetal antipsychotic exposure in a changing landscape: seeing the future.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 23637105.
- Also identified by DOI 10.1192/bjp.bp.112.117556.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pregnant women and their fetuses are increasingly likely to be exposed to antipsychotics. However, safety data remain limited. This editorial suggests that, in future, well-designed observational pharmaco-epidemiology is our best chance of illuminating risk for exposed populations and of informing decision-making for women and clinicians.
Medical subject headings
- Antipsychotic Agents
- Prenatal Exposure Delayed Effects